glp 1 obesity treatment BMI and GLP-1 Weight Loss Treatment: What BMI Qualifies? The World Health Organization is

In a clinical trial of daily administered oral semaglutide (2.5 to 40 mg) for 26 weeks in patients with T2DM, the dose-dependent range in the reduction of hemoglobin A1c induced was -0.7% to -1.9%, whereas those induced by 1 mg weekly administered semaglutide through the subcutaneous route and oral placebo were -1.9% and -0.3%, respectively [49]

The combined effect on central nervous system pathways that control appetite and satiety appears more potent than GLP-1 monotherapy

Excessive glutamate in the PFC and striatum has also been linked to withdrawal symptoms (Hinton et al., 2012

Additional research was initiated to delve deeper into the action of the compound on the contractile potential of the stomachs smooth muscles, which were activated by acetylcholine and electrical field stimulation

References Chatterjee A

Use within 3-4 weeks for optimal potency, though some degradation occurs progressively from the time of reconstitution